CD34 and hemorrhagic stroke: In summary, the data demonstrate that the understudied cd45- [cd34/kdr+]EPC subset comprise juvenile protective factors whose quantitative and qualitative normalization can attenuate the progression of ischemic-hemorrhagic stroke pathogenesis in the spTg25 rat model likely through the maintenance of brain microvascular health.